Profile data is unavailable for this security.
About the company
Patrys Limited is an Australia-based company. The Company is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different indications. The Company’s deoxymab platform is based on the deoxymab 3E10 antibody that is identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus (SLE). It has developed two humanized forms of deoxymab 3E10, called PAT-DX1 and PAT-DX3, which have improved activity over the original 3E10 antibody. PAT-DX1 is a dimer of a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10. PAT-DX3 is a humanized, full-sized antibody that has been further optimized to improve its therapeutic potential. It is also focused on developing RLS-2201, a proprietary injectable formulation of quetiapine.
- Revenue in AUD (TTM)100.38k
- Net income in AUD-4.51m
- Incorporated2006
- Employees15.00
- LocationPatrys LtdLevel 4, 96-100 Albert RoadSOUTH MELBOURNE 3205AustraliaAUS
- Phone+61 39670-3273
- Fax+61 39670-3247
- Websitehttps://patrys.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imagion Biosystems Ltd | 1.06m | -2.20m | 9.81m | -- | -- | -- | -- | 9.29 | -0.0177 | -0.0177 | 0.0082 | -0.0192 | 1.45 | -- | 1,173.13 | -- | -302.58 | -76.63 | -- | -102.36 | -- | -- | -208.52 | -911.24 | -- | -0.7972 | -- | -- | -18.54 | 22.02 | 83.43 | -- | -- | -- |
| BPH Energy Ltd | 914.02k | -1.21m | 10.83m | 2.00k | -- | 0.2569 | -- | 11.85 | -0.001 | -0.001 | 0.0008 | 0.0311 | 0.0235 | -- | 8.56 | -- | -3.10 | 9.05 | -3.15 | 9.45 | -- | -- | -132.17 | 431.04 | -- | -0.8233 | 0.0022 | -- | -0.8344 | 28.34 | 48.93 | 43.33 | -- | -- |
| Cambium Bio Ltd | 719.38k | -3.57m | 11.25m | -- | -- | 4.35 | -- | 15.64 | -0.2766 | -0.2766 | 0.0455 | 0.1126 | 0.2011 | -- | 4.09 | -- | -99.90 | -41.30 | -150.85 | -75.44 | 70.61 | -- | -496.86 | -118.71 | -- | -- | 0.1378 | -- | 419.43 | -16.63 | -70.42 | -- | -- | -- |
| Adalta Ltd | 626.72k | -4.36m | 11.47m | -- | -- | -- | -- | 18.31 | -0.0039 | -0.0039 | 0.0005 | -0.0001 | 0.2993 | -- | 1.70 | -- | -208.36 | -70.41 | -611.82 | -126.24 | -- | -- | -696.16 | -207.18 | -- | -15.14 | -- | -- | -61.02 | -28.97 | 16.33 | -- | -- | -- |
| Nexsen Ltd | -100.00bn | -100.00bn | 14.38m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.44 | -- | -605,140.90 | -- | -- | -- |
| Neurotech International Ltd | 2.47m | -3.85m | 16.85m | -- | -- | 2.87 | -- | 6.81 | -0.0037 | -0.0037 | 0.0024 | 0.0045 | 0.3738 | -- | 5.87 | -- | -58.15 | -130.68 | -66.30 | -148.27 | -- | -- | -155.58 | -428.93 | -- | -- | 0.00 | -- | -22.61 | 99.30 | -109.08 | -- | -- | -- |
| Patrys Ltd | 100.38k | -4.51m | 18.74m | 15.00 | -- | 8.00 | -- | 186.67 | -0.0194 | -0.0194 | 0.0004 | 0.0044 | 0.0374 | -- | 0.2562 | -- | -167.95 | -58.09 | -260.40 | -63.36 | -- | -- | -4,497.10 | -250.93 | -- | -- | 0.00 | -- | -40.57 | 1.40 | 14.86 | -- | -- | -- |
| Noxopharm Ltd | 2.83m | -4.88m | 18.74m | 1.00k | -- | 25.84 | -- | 6.62 | -0.0167 | -0.0167 | 0.0097 | 0.0024 | 0.4979 | -- | 1.06 | -- | -85.95 | -49.70 | -156.33 | -59.16 | -- | -- | -172.63 | -229.01 | -- | -- | 0.7823 | -- | 17.54 | -19.45 | -36.50 | -- | -- | -- |
| IDT Australia Ltd | 19.12m | -6.13m | 19.66m | 156.00 | -- | 0.9679 | -- | 1.03 | -0.0143 | -0.0143 | 0.0445 | 0.0475 | 0.530 | 1.38 | 2.25 | -- | -16.99 | -13.43 | -21.44 | -16.06 | 80.54 | 79.42 | -32.06 | -30.01 | 2.38 | -3.82 | 0.3268 | -- | 40.65 | 6.99 | -48.96 | -- | 11.30 | -- |
| BTC Health Ltd | 3.28k | -1.04m | 22.52m | 1.00 | -- | 2.04 | -- | 6,865.74 | -0.0033 | -0.0033 | 0.00001 | 0.031 | 0.0003 | -- | -- | -- | -9.70 | -13.71 | -9.92 | -14.66 | -- | -- | -31,820.43 | -3,966.34 | -- | -0.9016 | 0.0066 | -- | -39.12 | -43.28 | 277.27 | -- | -- | -- |
| Holista Colltech Limited | 5.79m | -948.92k | 23.91m | 3.00 | -- | 21.36 | -- | 4.13 | -0.0025 | -0.0025 | 0.0157 | 0.003 | 1.26 | 2.91 | 5.30 | -- | -20.65 | -33.97 | -761.62 | -85.93 | 51.96 | 54.37 | -16.43 | -26.33 | 0.6827 | -8.79 | 1.36 | -- | 3.34 | -4.08 | -848.26 | -- | 11.81 | -- |
| Algorae Pharmaceuticals Ltd | 141.05k | -802.96k | 23.91m | -- | -- | 10.60 | -- | 169.52 | -0.0005 | -0.0005 | 0.00008 | 0.0013 | 0.0505 | -- | 3.38 | -- | -28.72 | -51.95 | -30.63 | -56.76 | -- | -- | -569.27 | -1,452.78 | -- | -- | 0.00 | -- | 12.66 | -23.93 | 61.68 | -- | -- | -- |
